FMLA for Mental Health: Certification, Intermittent Tracking, and Privacy (2026)

Mental Health as an FMLA Serious Health Condition

Mental health conditions represent the fastest-growing category of FMLA leave requests in the United States, accounting for over 20,000 monthly search inquiries. Under Department of Labor regulations (29 CFR § 825.115), mental health conditions are fully recognized as qualifying 'serious health conditions' whenever they cause inpatient hospitalization or continuing treatment by a healthcare provider.

Qualifying Diagnoses: Major depressive disorder, generalized anxiety disorder, post-traumatic stress disorder (PTSD), bipolar disorder, severe obsessive-compulsive disorder (OCD), and substance abuse disorder treatment.

The Chronic Condition Standard: 29 CFR § 825.115(c)

Most psychiatric conditions qualify as 'chronic serious health conditions.' To meet this statutory benchmark, the condition must satisfy three criteria: (1) Require periodic visits for treatment by a healthcare provider (at least twice per year); (2) Continue over an extended period of time; and (3) Cause episodic periods of incapacity rather than a continuing period of incapacity (e.g. sudden panic attacks, acute depressive episodes).

Navigating Psychiatric Privacy on Form WH-380-E

Employers frequently create legal liability by demanding psychiatric therapy notes or detailed clinical evaluations. Under 29 CFR § 825.306(a)(4), an employer cannot demand diagnostic details, psychotherapy session transcripts, or DSM-5 criteria.

It is legally sufficient if the treating psychologist, psychiatrist, or licensed clinical social worker (LCSW) certifies that the worker has a serious health condition, provides estimated frequency/duration of episodes (e.g. 1-2 flare-ups per month lasting 1-2 days), and confirms that during episodes the employee is unable to perform essential job functions.

Substance Abuse Treatment: A Critical Statutory Distinction (29 CFR § 825.119)

Under 29 CFR § 825.119, FMLA leave is available for substance abuse treatment provided by a healthcare provider or by a provider of healthcare services upon referral. However, absence because of the employee's use of the substance, rather than for treatment, does not qualify for FMLA leave.

Employers may still enforce pre-established, non-discriminatory drug-free workplace policies.